Lexicon Pharmaceuticals Overview
Founded
1995
Status
Public
Employees
184
Stock Symbol
LXRX
Investments
3
Share Price
$1.89
(As of Thursday Closing)
Lexicon Pharmaceuticals General Information
Description
Lexicon Pharmaceuticals Inc is a biopharmaceutical company developing medicines that transform patients' lives. The company commercializes and develops drugs and drug candidates. Its drugs candidates include XERMELO (telotristat ethyl), an orally-delivered small molecule drug, in the United States for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog, or SSA, therapy in adults inadequately controlled by SSA therapy; Zynquista (sotagliflozin), an orally-delivered small molecule drug candidate, as a treatment for type 1 diabetes; sotagliflozin as a treatment for type 2 diabetes, heart failure and chronic kidney disease; and LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain.
Contact Information
Website
Formerly Known As
Lexicon Genetics
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
NAS
Primary Office
- 8800 Technology Forest Place
- The Woodlands, TX 77381
- United States
+1 (281) 000-0000
Lexicon Pharmaceuticals Stock Performance
(As of Tuesday closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.89 | $1.89 | $1.12 - $6.72 | $202M | 107M | 944K | $0.80 |
Lexicon Pharmaceuticals Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
|---|---|---|---|---|
| EV | 183,217 | 389,850 | 760,993 | 946,535 |
| Revenue | 320,856 | 322,073 | 63,209 | 91,689 |
| EBITDA | 100,135 | 145,099 | (99,596) | (127,225) |
| Net Income | 85,319 | 130,133 | (120,548) | (122,993) |
| Total Assets | 370,567 | 417,715 | 284,136 | 436,539 |
| Total Debt | 245,222 | 246,285 | 245,002 | 245,670 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Lexicon Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Lexicon Pharmaceuticals‘s full profile, request access.
Request a free trial
Lexicon Pharmaceuticals Competitors (50)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Intercept(Biotechnology) | Formerly VC-backed | New York, NY | 000 | 00000 | 000000 - 000 | 00000 |
| 000000000 | Formerly VC-backed | South San Francisco, CA | 00000 | 000.00 | 00000000000 | |
| 00000 000000000000 | Venture Capital-Backed | San Diego, CA | 00 | 0000 | 000000 - 000 | 0000 |
| 0000000 0000000000 | Corporation | San Diego, CA | 00 | 00000 | 000000 - 000 | 00000 |
| 000000000 00000000 | Formerly VC-backed | Charlottesville, VA | 00 | 000.00 | 00000000000 | 000.00 |
Lexicon Pharmaceuticals Executive Team (12)
5 Former Executives
Lexicon Pharmaceuticals Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000 0000 00 | Self | Board Member | 000 0000 |
| 00000000000 0000000 | The Invus Group | Board Member | 000 0000 |
| 00000 000000000 | Self | Board Member | 000 0000 |
| 000000 00000 | Self | Board Member | 000 0000 |
| 000000 00000 | Lexicon Pharmaceuticals | Chief Executive Officer & Board Member | 000 0000 |
Lexicon Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Lexicon Pharmaceuticals‘s full profile, request access.
Request a free trial
Lexicon Pharmaceuticals Investments & Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 0000 | 02-Aug-2010 | 000000000000000000 | 0000 | Pharmaceuticals | 000000 00000 00.0 |
| 00000000 0000 | 01-Jun-2007 | 00000 0000000 | Pharmaceuticals | 000000 00000 00.0 | |
| Coelacanth Chemical | 12-Jul-2001 | Merger/Acquisition | 0000 | Pharmaceuticals | 000000 00000 00.0 |
Ready to get started?
Request a free trial